Valuation: Haleon plc

Market Cap 31.32B 42.41B 36.63B 34.47B 58.92B 4,064B 59.78B 404B 158B 2,032B 159B 156B 6,770B P/E 2026 *
18.5x
P/E 2027 * 16.3x
Enterprise Value 38.19B 51.71B 44.66B 42.02B 71.83B 4,954B 72.88B 493B 193B 2,478B 194B 190B 8,253B EV / Sales 2026 *
3.35x
EV / Sales 2027 * 3.18x
Free-Float
98.46%
Yield 2026 *
2.27%
Yield 2027 * 2.52%
1 day+1.81%
1 week+0.17%
Current month-0.77%
1 month-2.83%
3 months+5.32%
6 months-11.45%
Current year-3.82%
1 week 348.8
Extreme 348.8
360.7
1 month 348.8
Extreme 348.8
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+0.17%-0.06%+12.01% 42.41B
+5.32%+5.68%+83.39%+134.45% 1,093B
+1.79%+5.62%+54.97%+64.64% 653B
+2.59%+6.91%+28.98%+77.11% 458B
+1.70%+0.30%+40.89%+44.16% 355B
+1.34%+2.61%+26.30%+41.60% 294B
+2.73%+3.44%+2.74%+13.41% 248B
+3.44%+6.09%+49.39%+69.36% 230B
+1.79%+0.83%-13.23%-52.11% 203B
+3.64%+9.38%+25.97%+95.71% 178B
Average +2.63%+0.81%+29.93%+50.03% 375.29B
Weighted average by Cap. +3.13%+1.41%+47.02%+74.21%

Financials

2026 *2027 *
Net sales 11.39B 15.43B 13.32B 12.53B 21.43B 1,478B 21.74B 147B 57.62B 739B 57.91B 56.66B 2,462B 11.87B 16.08B 13.89B 13.06B 22.33B 1,540B 22.66B 153B 60.06B 770B 60.36B 59.05B 2,566B
Net income 1.7B 2.3B 1.98B 1.87B 3.19B 220B 3.24B 21.9B 8.58B 110B 8.63B 8.44B 367B 1.92B 2.6B 2.25B 2.11B 3.61B 249B 3.67B 24.79B 9.71B 125B 9.76B 9.55B 415B
Net Debt 6.86B 9.29B 8.03B 7.55B 12.91B 891B 13.1B 88.6B 34.72B 445B 34.9B 34.14B 1,484B 6.42B 8.7B 7.51B 7.07B 12.08B 833B 12.26B 82.91B 32.49B 417B 32.66B 31.95B 1,388B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-08-19 GBX 360.20 +1.29% 5,529,042
26-08-18 GBX 355.60 +1.54% 21,852,263
26-08-17 GBX 350.20 -1.52% 11,334,933
26-08-14 GBX 355.60 -0.64% 6,422,346
26-08-13 GBX 357.90 -0.56% 13,056,164
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.556GBP
Average target price
4.208GBP
Spread / Average Target
+18.34%

Quarterly revenue - Rate of surprise